Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and infection anxiety on adherence and ability to self-inject
- 428 Downloads
The management of many chronic illnesses involves medications that must be injected on a frequent basis. With fewer support resources available, patients are increasingly being obliged to manage injectable medications themselves. Interferon beta-1a (IFNβ-1a), recommended for the treatment of multiple sclerosis (MS), must be injected intramuscularly on a weekly basis. Patients are generally advised and taught to self-inject, if possible. This longitudinal study examined cognitive and affective contributions to the ability to self-inject and adherence to IFNβ-1a over 6 months following initiation of medication. Participants were 101 patients with a relapsing form of MS. Injection self-efficacy expectations, injection anxiety, adherence expectations, method of injection administration, and 6-month adherence to IFNβ-1a were fitted to a path analytic model Pretreatment injection self-efficacy expectations were significantly related to 6-month adherence. This relation was mediated by the patient's ability to self-inject. Patients’experienced level of injection anxiety was related to adherence but not to method of injection.
Unable to display preview. Download preview PDF.
- (2).Goodkin DE: The natural history of multiple sclerosis. In Rudick RA, Goodkin DE (eds), Treatment of Multiple Sclerosis: Trial Design, Results and Future Perspectives. New York: Springer-Verlag, 1992, 7–46.Google Scholar
- (3).Mohr DC, Dick LP: Multiple sclerosis. In Camic PM, Knight S (eds). Clinical Handbook of Health Psychology: A Practical Guide to Effective Interventions. Seattle: Hogrefe & Huber, 1998, 313–348.Google Scholar
- (5).The IFNB Multiple Sclerosis Study Group: Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. 1. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial.Neurology. 1993,43:655–661.Google Scholar
- (7).American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th Ed.). Washington, DC: American Psychiatric Association, 1994.Google Scholar
- (14).Johnson SB: Compliance and control in insulin-dependent diabetes: Does behavior really make a difference? In Scheiderman N, McCabe P, Baum A (eds), Perspectives in Behavioral Medicine: Stress and Disease Processes. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc., 1992, 275–297.Google Scholar
- (23).Benton AL, Hamsher KdS:Multilingual Aphasia Examination. Iowa City, Iowa: AJA Associates, 1989.Google Scholar
- (26).Welsh KA, Breitner JCS, Magruder-Habib KM: Detection of dementia in elderly using telephone screening of cognitive status.Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 1993,6:103–110.Google Scholar
- (32).StatSoft, Inc.: Statistica (1998 Ed., Ver. 6.0). Tulsa, OK: StatSoft, Inc., 1998.Google Scholar
- (33).Carmines EG, McIver JP: Analyzing models with unobserved variables: Analysis of covariance structures. In Bohrnstedt GW, Borgatta EF (eds).Social Measurement: Current Issues. Beverly Hills, CA: Sage, 1981, 63–115.Google Scholar
- (34).Tabachnick BG, Fidell LS:Using Multivariate Statistics (3rd Ed.). New York: HarperCollins, 1996.Google Scholar